Elanco Animal Health 

€13.39
32
+€0+0% 今天

统计数据

当日最高
13.39
当日最低
13.39
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
6.46B
市盈率
-
股息收益率
-
股息
-

即将到来

收益

5Nov预期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
0.05
0.18
0.32
0.45
预期每股收益
0.128753
实际每股收益
N/A

人们还关注

此列表基于关注5EA.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Show more...
首席执行官
Mr. Jeffrey N. Simmons
员工
9300
国家
US
ISIN
US28414H1032
WKN
000A2N6BH

上市公司